However, for myasthenia, clinical assessment and neurophysiological studies overrule the biomarkers (anticholinesterase (anti-ACR) and muscle-specific tyrosine kinase (anti-MUSK) antibodies) in comparison to non-ICI-induced myasthenia gravis [4,6-8]. Here, EIF3K is linked to Fatigable weakness.